Turning Cancer Patients and Caregivers Into Informed Decision- Makers 


Hi, my name is David Emerson, and I have been living with an incurable cancer called Multiple Myeloma since 1994. I started PeopleBeatingCancer.org because I believe that there is a problem with cancer care today.  Cancer patients and caregivers are asked to make huge decisions about their health-- often while woefully uninformed, and under an extreme time crunch. How many of you are here because you were given 24 hours to approve your chemotherapy regimen? 

Let me be clear: knowledge is power. The more you know, the better decisions you'll make for your care.  Yes, I said YOU. You are in control. This website and the non-profit organization that supports it are dedicated to helping cancer survivors and caregivers become informed, educated decision-makers about their treatment. All information found on this site is evidence-based with the studies cited, and actionable-- you can get started using the protocols right away.


Check out our latest blog posts:

4 Signs It’s Time to Seek Help for Addiction
Beating addiction often requires expert assistance to get through the worst periods until you are comfortable managing alone. Research suggests[...]
Will Ductal Carcinoma In-Situ (DCIS) Patients Accept Breast Cancer Risk?
“Our thought is that seeing loved ones go through the severe side effects associated with breast cancer made them think[...]
Bladder Cancer Therapy beyond Bacillus Calmette-Guérin (BCG)
The agent (CG0070) yielded an overall 12-month complete response (CR) rate of 30% in a phase 2 single-arm trial in[...]
Exercise Enhances Brain Training
"These enhancements in memory were most striking among the volunteers whose fitness had also improved the most, especially if they[...]
Head & Neck Cancer- An Integrative Therapy no-brainer-
The Life of a Head & Neck Cancer Survivor is all about Risks. The Risk of Collateral Damage, the Risk[...]
The “BEST” Treatments for Basel Cell Carcinoma?
“In order for clinicians, patients, and payers to make informed decisions about treating Basel Cell Carcinoma, new RCT or high-quality[...]